by Alyson Lam | Jul 14, 2026 | US & International
Overview Broad antibody claims have faced a difficult path in the US since Amgen v Sanofi, particularly where the claim covers a large functional genus. The Federal Circuit’s decision in Teva v Eli Lilly is therefore interesting because the court drew an important...
by Chloe Sullivan | Jul 8, 2026 | Trademarks
Back in 2018, The Estate of the Late Sonia Brownell Orwell applied to register the word marks “ANIMAL FARM” and “1984” as EU trade marks. The application to register “ANIMAL FARM” covered goods and services in classes 9, 16, 28 and 41, whilst the application to...
by Sean Hughes | Jun 22, 2026 | EPO
Admissibility: Should the Enlarged Board Answer at All? The first question in G 1/26 is procedural. The referring Board asks whether a referral is “required” under Article 112(1) EPC where the legal issue arises in the pending case but the Board has not...
by Vicky Colley | Jun 19, 2026 | Trademarks, Uncategorised
Background On 23 November 2020, Iron & Smith Kft. filed a European trade mark application for “BRIETLING FOR WOMEN” in class 3 for the following aromatic, perfumery goods and cosmetics:- Class 3: Aromatic oils; Aromatherapy oil; Skin care oils [non-medicated];...
by Agne Augustinaite | Jun 16, 2026 | UPC
Background The Claimant, Agathon, was the proprietor of a European patent relating to a mechanical system designed to improve alignment in industrial machinery. Particularly, the invention concerns the repeated opening and closing of heavy metal components where...
by David Eyre | Jun 9, 2026 | Trademarks
While our two Gaulish friends may appear inseparable, their names, and the trade marks attached to their names, are individuals and in this case the trade mark Obelix in classes 9, 16, 25, 28 and 41 (covering products ranging from printed matter to games, playthings,...
Recent Comments